APA (7th ed.) Citation

N, G., F, G., A, V., S, C., M, G., SM, P., . . . M, B. (2025). Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections. Infection, 53(5), 2243. https://doi.org/10.1007/s15010-025-02603-y

Chicago Style (17th ed.) Citation

N, Geremia, et al. "Risk Factors for 30-Day Mortality and the Role of Empirical Therapy in Pseudomonas Aeruginosa Bloodstream Infections." Infection 53, no. 5 (2025): 2243. https://doi.org/10.1007/s15010-025-02603-y.

MLA (9th ed.) Citation

N, Geremia, et al. "Risk Factors for 30-Day Mortality and the Role of Empirical Therapy in Pseudomonas Aeruginosa Bloodstream Infections." Infection, vol. 53, no. 5, 2025, p. 2243, https://doi.org/10.1007/s15010-025-02603-y.